Invesco’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Invesco’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-230,241	Closed	-$583K	–	3990
2023 Q4	$583K	Buy	230,241 +14,928	+7%	+$34.8K	﹤0.01%	3138
2023 Q3	$515K	Buy	215,313 +2,119	+1%	+$4.69K	﹤0.01%	3187
2023 Q2	$492K	Sell	213,194 -4,883	-2%	-$13.8K	﹤0.01%	3250
2023 Q1	$556K	Buy	218,077 +164,824	+310%	+$472K	﹤0.01%	3200
2022 Q4	$134K	Sell	53,253 -713	-1%	-$1.99K	﹤0.01%	3776
2022 Q3	$156K	Buy	53,966 +852	+2%	+$3.59K	﹤0.01%	3746
2022 Q2	$240K	Buy	+53,114	New	+$316K	﹤0.01%	3653

Invesco's SLGC Position: Q1 2024 in Review

Invesco sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 230,241 shares — an estimated $583K sold.

Invesco first reported a position in SLGC in Q2 2022 and held it in 7 quarters. The position peaked at $583K in Q4 2023. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Invesco reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Invesco sold 230,241 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $583K.
Invesco first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2022 and held it in 7 quarters.
Invesco's SomaLogic, Inc. Class A Common Stock position peaked at $583K in Q4 2023.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Invesco's 13F filing for Q1 2024, filed 14 May 2024.